Insufficient scRNA-seq data for expression of SH2D1A at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 99% | 295.41 | 574 / 578 | 84% | 4.27 | 967 / 1155 |
breast | 66% | 59.55 | 302 / 459 | 69% | 4.07 | 766 / 1118 |
esophagus | 72% | 214.34 | 1034 / 1445 | 54% | 1.68 | 98 / 183 |
prostate | 66% | 58.31 | 162 / 245 | 56% | 3.23 | 279 / 502 |
stomach | 59% | 35.55 | 213 / 359 | 59% | 2.31 | 169 / 286 |
uterus | 58% | 37.40 | 98 / 170 | 60% | 2.57 | 274 / 459 |
kidney | 47% | 50.89 | 42 / 89 | 70% | 3.72 | 627 / 901 |
thymus | 68% | 89.26 | 443 / 653 | 49% | 38.25 | 296 / 605 |
intestine | 61% | 94.60 | 587 / 966 | 53% | 1.73 | 281 / 527 |
liver | 77% | 60.77 | 175 / 226 | 35% | 1.23 | 141 / 406 |
bladder | 52% | 63.52 | 11 / 21 | 49% | 1.79 | 247 / 504 |
spleen | 100% | 807.90 | 241 / 241 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 97% | 35.90 | 28 / 29 |
peripheral blood | 88% | 481.28 | 822 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 87% | 6.76 | 39 / 45 |
adipose | 84% | 123.43 | 1011 / 1204 | 0% | 0 | 0 / 0 |
skin | 19% | 9.58 | 352 / 1809 | 62% | 5.31 | 294 / 472 |
pancreas | 3% | 1.88 | 11 / 328 | 60% | 2.94 | 107 / 178 |
ovary | 18% | 10.28 | 33 / 180 | 31% | 0.70 | 134 / 430 |
blood vessel | 41% | 38.67 | 552 / 1335 | 0% | 0 | 0 / 0 |
brain | 23% | 10.49 | 599 / 2642 | 9% | 0.19 | 64 / 705 |
adrenal gland | 17% | 8.42 | 43 / 258 | 13% | 0.24 | 29 / 230 |
heart | 23% | 12.68 | 196 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 13% | 0.69 | 10 / 80 |
muscle | 5% | 2.33 | 39 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0002250 | Biological process | adaptive immune response |
GO_0006968 | Biological process | cellular defense response |
GO_0006959 | Biological process | humoral immune response |
GO_0045954 | Biological process | positive regulation of natural killer cell mediated cytotoxicity |
GO_0050776 | Biological process | regulation of immune response |
GO_0007267 | Biological process | cell-cell signaling |
GO_0050860 | Biological process | negative regulation of T cell receptor signaling pathway |
GO_0042267 | Biological process | natural killer cell mediated cytotoxicity |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005515 | Molecular function | protein binding |
Gene name | SH2D1A |
Protein name | SH2 domain containing 1A Truncated SH2 domain containing 1A SH2 domain containing 1A (SH2 domain protein 1A, Duncan's disease (Lymphoproliferative syndrome), isoform CRA_a) SH2 domain-containing protein 1A (Duncan disease SH2-protein) (Signaling lymphocytic activation molecule-associated protein) (SLAM-associated protein) (T-cell signal transduction molecule SAP) |
Synonyms | DSHP hCG_15647 SAP |
Description | FUNCTION: Cytoplasmic adapter regulating receptors of the signaling lymphocytic activation molecule (SLAM) family such as SLAMF1, CD244, LY9, CD84, SLAMF6 and SLAMF7. In SLAM signaling seems to cooperate with SH2D1B/EAT-2. Initially it has been proposed that association with SLAMF1 prevents SLAMF1 binding to inhibitory effectors including INPP5D/SHIP1 and PTPN11/SHP-2 . However, by simultaneous interactions, recruits FYN which subsequently phosphorylates and activates SLAMF1 . Positively regulates CD244/2B4- and CD84-mediated natural killer (NK) cell functions. Can also promote CD48-, SLAMF6 -, LY9-, and SLAMF7-mediated NK cell activation. In the context of NK cell-mediated cytotoxicity enhances conjugate formation with target cells (By similarity). May also regulate the activity of the neurotrophin receptors NTRK1, NTRK2 and NTRK3. . |
Accessions | K7XSE5 ENST00000698116.1 [O60880-1] K7YQB3 ENST00000698117.1 K7XXT7 ENST00000698113.1 [O60880-1] O60880 ENST00000477673.2 [O60880-5] ENST00000647259.2 A0A8V8TLH8 ENST00000494073.5 [O60880-6] ENST00000491950.5 [O60880-3] ENST00000371139.9 [O60880-1] ENST00000360027.5 [O60880-4] ENST00000698118.1 [O60880-1] A0A2R8Y573 |